3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
3
Active not recruiting
3
Recruiting
2
Unknown
1
Sponsor Class
NIH
1
INDUSTRY
1
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Uterine Cervical Neoplasms
6
Uterine Cervical Dysplasia
2
Uterine Cervical Diseases
2
Squamous Intraepithelial Lesions
2
Papillomavirus Infections
2
Genital Diseases
2
Uterine Neoplasms
1
Uterine Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Sexually Transmitted Diseases, Viral
1
Sexually Transmitted Diseases
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Female Urogenital Diseases and Pregnancy Complications
1
Atypical Squamous Cells of the Cervix
1
Interventions
Human Papillomavirus Recombinant Vaccine nonavalent
3
epigallocatechin gallate
2
artesunic acid
2
artemisinin
2
Transurethral Resection of Prostate
2
Surveys and Questionnaires
2
Papillomavirus Vaccines
2
Cytological Techniques
2
Colposcopy
2
Cisplatin
2
Carboplatin
2
Blood Specimen Collection
2
toripalimab
1
human papillomavirus vaccine, L1 type 16, 18
1
artenimol
1
Vitamin B 12
1
Vaccination
1
Triage
1
Standing Orders
1
Specimen Handling
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Mass Screening
1
Liquid Biopsy
1
Lacteol
1
Imiquimod
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Human Papillomavirus DNA Tests
1
Folic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Papillomavirus Infections
×
Colposcopy
×
Clear all
NCT07281430
2026-05-13
LMI-001-A-S04
National Cancer Institute (NCI)
Phase NA
Recruiting
500 enrolled
NCT07281599
2026-02-02
EQUIP
Qurasense
Phase NA
Recruiting
450 enrolled